Literature DB >> 27777526

What's New in Anticoagulation.

Joanna Esther Molina Razavi, Payam Safavi-Naeini, Mehdi Razavi.   

Abstract

Keywords:  Anticoagulants/administration & dosage/therapeutic use; United States/epidemiology; atrial fibrillation/drug therapy; factor Xa inhibitors; heart diseases/therapy; metabolic clearance rate; practice guidelines as topic; risk factors; vitamin K/antagonists & inhibitors

Mesh：

Substances：

Year:  2016        PMID： 27777526      PMCID： PMC5067036          DOI： 10.14503/THIJ-16-5920

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  10 in total

1.  Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor.

Authors:  Dagmar Kubitza; Michael Becka; Wolfgang Mueck; Atef Halabi; Haidar Maatouk; Norbert Klause; Volkmar Lufft; Dominic D Wand; Thomas Philipp; Heike Bruck
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

2.  Heart disease and stroke statistics--2015 update: a report from the American Heart Association.

Authors:  Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Joshua Z Willey; Daniel Woo; Robert W Yeh; Melanie B Turner
Journal:  Circulation       Date:  2014-12-17       Impact factor: 29.690

3.  Target-specific oral anticoagulants: should we switch from warfarin?

Authors:  Payam Safavi-Naeini; Mohammad Saeed
Journal:  Tex Heart Inst J       Date:  2015-06-01

Review 4.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

5.  Idarucizumab for Dabigatran Reversal.

Authors:  Charles V Pollack; Paul A Reilly; John Eikelboom; Stephan Glund; Peter Verhamme; Richard A Bernstein; Robert Dubiel; Menno V Huisman; Elaine M Hylek; Pieter W Kamphuisen; Jörg Kreuzer; Jerrold H Levy; Frank W Sellke; Joachim Stangier; Thorsten Steiner; Bushi Wang; Chak-Wah Kam; Jeffrey I Weitz
Journal:  N Engl J Med       Date:  2015-06-22       Impact factor: 91.245

Review 6.  New oral Xa and IIa inhibitors: updates on clinical trial results.

Authors:  Sylvia Haas
Journal:  J Thromb Thrombolysis       Date:  2007-10-27       Impact factor: 2.300

7.  Apixaban metabolism and pharmacokinetics after oral administration to humans.

Authors:  Nirmala Raghavan; Charles E Frost; Zhigang Yu; Kan He; Haiying Zhang; W Griffith Humphreys; Donald Pinto; Shiangyuan Chen; Samuel Bonacorsi; Pancras C Wong; Donglu Zhang
Journal:  Drug Metab Dispos       Date:  2008-10-02       Impact factor: 3.922

Review 8.  Update on Edoxaban for the Prevention and Treatment of Thromboembolism: Clinical Applications Based on Current Evidence.

Authors:  Ali Zalpour; Thein Hlaing Oo
Journal:  Adv Hematol       Date:  2015-08-16

Review 9.  Management of non-vitamin K antagonist oral anticoagulants in the perioperative setting.

Authors:  Anne-Sophie Dincq; Sarah Lessire; Jonathan Douxfils; Jean-Michel Dogné; Maximilien Gourdin; François Mullier
Journal:  Biomed Res Int       Date:  2014-09-03       Impact factor: 3.411

Review 10.  Novel Anticoagulants in Atrial Fibrillation: Monitoring, Reversal and Perioperative Management.

Authors:  Fadi Shamoun; Hiba Obeid; Harish Ramakrishna
Journal:  Biomed Res Int       Date:  2015-07-02       Impact factor: 3.411
  10 in total
  1 in total

1.  Medical and Device Therapy for Stroke Prevention in Patients With Atrial Fibrillation.

Authors:  Sophia Huang; Payam Safavi-Naeini; Abdi Rasekh
Journal:  Tex Heart Inst J       Date:  2021-09-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.